Latest filings (excl ownership)
8-K
Regulation FD Disclosure
20 Apr 20
8-K
Monthly Operating Report
25 Mar 20
8-K
Other Events
16 Mar 20
8-K
Monthly Operating Report
13 Feb 20
8-K
Other Events
31 Jan 20
8-K
Monthly Operating Report
15 Jan 20
8-K
Monthly Operating Report
31 Dec 19
25-NSE
Exchange delisting
17 Dec 19
8-K
Cost Associated with Exit or Disposal Activities
22 Nov 19
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
14 Nov 19
8-K
Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11
13 Nov 19
8-K
Other Events
18 Oct 19
8-K
Departure of Directors or Certain Officers
20 Sep 19
8-K
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
29 Aug 19
10-Q
2019 Q2
Quarterly report
31 Jul 19
8-K
Nuvectra® Reports Second Quarter 2019 Financial Results
31 Jul 19
EFFECT
Notice of effectiveness
26 Jul 19
CORRESP
Correspondence with SEC
23 Jul 19
UPLOAD
Letter from SEC
22 Jul 19
8-K
Entry into a Material Definitive Agreement
15 Jul 19
S-3
Shelf registration
15 Jul 19
8-K/A
Entry into a Material Definitive Agreement
10 Jul 19
8-K
Departure of Directors or Certain Officers
28 Jun 19
8-K
Other Events
18 Jun 19
8-K
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval
11 Jun 19
8-K
Submission of Matters to a Vote of Security Holders
24 May 19
SD
Conflict minerals disclosure
17 May 19
8-K
Departure of Directors or Certain Officers
16 May 19
S-8
Registration of securities for employees
1 May 19
10-Q
2019 Q1
Quarterly report
1 May 19
8-K
Nuvectra® Reports First Quarter 2019 Financial Results
1 May 19
8-K
Entry into a Material Definitive Agreement
26 Apr 19
DEF 14A
Definitive proxy
5 Apr 19
8-K
Nuvectra® Appoints Anthony P. Bihl, III as New Chairman
25 Mar 19
10-K
2018 FY
Annual report
4 Mar 19
8-K/A
Departure of Directors or Certain Officers
1 Mar 19
8-K
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results
28 Feb 19
8-K
Entry into a Material Definitive Agreement
5 Feb 19
8-K
Other Events
29 Jan 19
8-K
Nuvectra Announces Divesture of NeuroNexus Subsidiary
7 Jan 19
Latest ownership filings
SC 13G/A
GILDER GAGNON HOWE & CO LLC
16 Feb 21
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
SC 13G
Nuvectra Corp
14 Feb 20
4
DAVID D JOHNSON
26 Dec 19
4
KENNETH G HAWARI
26 Dec 19
4
Anthony P Bihl III
26 Dec 19
4
Jennifer Kosharek
16 Dec 19
4
Benjamin Tranchina
9 Dec 19
4
KENNETH G HAWARI
4 Dec 19
4
Jennifer Kosharek
25 Nov 19
4
Jennifer Kosharek
14 Nov 19
4
Thomas Edward Zelibor
23 Sep 19
4
Jon T Tremmel
23 Sep 19
4
JANE SONG
23 Sep 19
4
DAVID D JOHNSON
23 Sep 19
4
KENNETH G HAWARI
23 Sep 19
4
Christopher G. Chavez
23 Sep 19
4
Anthony P Bihl III
23 Sep 19
4
Benjamin Tranchina
19 Sep 19
4
Jennifer Kosharek
19 Sep 19
4
Jennifer Kosharek
13 Sep 19
4
Benjamin Tranchina
6 Sep 19
4
Jennifer Kosharek
14 Aug 19
SC 13G/A
Nuvectra Corp
10 Jul 19
4
Thomas Edward Zelibor
21 Jun 19
4
Jon T Tremmel
21 Jun 19
4
JANE SONG
21 Jun 19
4
DAVID D JOHNSON
21 Jun 19
4
KENNETH G HAWARI
21 Jun 19
4
Christopher G. Chavez
21 Jun 19
4
Anthony P Bihl III
21 Jun 19
4
Jennifer Kosharek
13 Jun 19
4
Joseph Paul Hanchin
7 Jun 19
4
Benjamin Tranchina
23 May 19
4
Jennifer Kosharek
13 May 19
4
Joseph Paul Hanchin
13 May 19
4
WALTER Z BERGER
13 May 19
4
KENNETH G HAWARI
7 May 19
4
DAVID D JOHNSON
6 May 19
4
Anthony P Bihl III
6 May 19